Modulation and detection of IDDM by membrane associated antigens from the islet beta cell line NIT-1

Journal of Autoimmunity

Volumn 10, Issue 1, 1997, Pages 27-34

  Reid, Bruce D ^a   Qin, Hui Yu ^a   Prange, Sean ^a   Lee Chan, Edwin ^a   Yu, Queendy ^a   Elliott, John F ^b   Singh, Bhagirath ^a,c  

^a ROBARTS RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF ALBERTA   (Canada)

^c UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

autoantibodies; beta cell antigens; diabetes; GAD; NIT 1 cells

Indexed keywords

AUTOANTIBODY; AUTOANTIGEN; GLUTAMATE DECARBOXYLASE; PANCREAS ISLET CELL ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL LINE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HELPER CELL; INSULIN DEPENDENT DIABETES MELLITUS; MOUSE; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION;

EID: 0031081477     PISSN: 08968411     EISSN: None     Source Type: Journal    
DOI: 10.1006/jaut.1996.9999     Document Type: Article

References (30)

1. Bach J.F. Insulin-dependent diabetes mellitus as an autoimmune disease. Endocrine Reviews. 15:1994;516-542.
2. Castano L., Eisenbarth G.S. Type 1 Diabetes: A chronic autoimmune diseae of human, mouse, and rat. Annu. Rev. Immunol. 8:1990;647-679.
3. Makino S., Kunimoto K., Muraoka Y., Mizushima Y., Katagiri K., Tochino Y. Breeding of non-obese diabetic strain of mice. Exp. Anim. 29:1980;1-13.
4. Hamaguchi K., Gaskins H.R., Leiter E.H. NIT-1, a pancreatic β-cell line established from a transgenic NOD/Lt mouse. Diabetes. 40:1991;842-849.
5. Hanahan D. Heritable formation of pancreatic β-cell tumors in transgenic mice expressing recombinant insulin/simian virus 40 oncogenes. Nature. 315:1985;115-122.
6. Harrison L.C. Islet cell antigens in insulin-dependent diabetes: Pandora's box revisited. Immunol. Today. 13:1992;348-352.
7. Palmer J.P., Asplin C.M., Clemons P., Lyen K., Tatpati O., Raghu P.K., Paquette T.L. Insulin antibodies in insulin-dependent diabetics before insulin treatment. Science. 222:1983;1337-1339.
8. Passini N., Larigan J.D., Genovese S., Appela E., Sinigaglia F., Rogge L. The 37/40-kilodalton autoantigen in insulin-dependent diabetes mellitus is the putative tyrosine phosphatase IA-2. Proc. Natl. Acad. Sci. USA. 92:1995;9412-9416.
9. Payton M.A., Hawkes C.J., Christie M. R. Relationship of the 37,000- and 40,000-M(r) tryptic fragments of islet antigens in insulin-dependent diabetes to the protein tyrosine phosphatase-like molecule IA-2 (ICA 512). J. Clin. Invest. 96:1995;1506-1511.
10. Baekkeskov S., Aanstoot H.J., Christgau S., Reetz A., Solimena M., Cascalho M., Folli F., Richter-Olesen H., DeCamilli P. Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase. Nature. 347:1990;151-156.
11. Faulkner-Jones B.E., Cram D.S., Kun J., Harrison L.C. Localization and quantitation of expression of two glutamate decarboxylase genes in pancreatic β-cells and other peripheral tissues of mouse and rat. Endocrinology. 133:1993;2962-2972.
12. Petersen J.S., Karlsen A.E., Markholst H., Worsaae A., Dyrberg T., Michelsen B. Neonatal tolerization with glutamic acid decarboxylase but not with bovine serum albumin delays the onset of diabetes in NOD mice. Diabetes. 43:1994;1478-1484.
13. Petersen J.S., Russel S., Marshall M.O., Kofod H., Buschard K., Cambon N., Karlsen A.E., Boel E., Hagopian W.A., Hejnaes K.R., Moody A., Dyrberg T., Lernmark A., Madsen O.D., Michelsen B.K. Differential expression of glutamic acid decarboxylase in rat and human islets. Diabetes. 42:1993;484-495.
14. Kaufman D.L., Clare-Salzler M., Tian J., Forsthuber T., Ting G.S.P., Robinson P., Atkinson M.A., Sercarz E.E., Tobin A.J., Lehmann P.V. Spontaneous loss of T-cell tolerance to glutamic acid decarboxylase in murine insulin-dependent diabetes. Nature. 366:1994;69-72.
15. Tisch R., Yang X.D., Singer S., Liblau R.S., Fugger L., McDevitt H.O. Immune response to glutamic acid decarboxylase correlates with insulitis in non-obese diabetic mice. Nature. 366:1994;72-75.
16. Elliott J.F., Qin H.Y., Bhatti S., Smith D.K., Singh R.K., Dillon T., Lauzon J., Singh B. Immunization with larger isoform of mouse glutamic acid decarboxylase (GAD67) prevents autoimmune diabetes in NOD mice. Diabetes. 43:1994;1494-1499.
17. Paul J. Cell and Tissue Culture 4th Ed. 1970;E&S Livingstone, Edinburgh.
18. Freshney R.I. Animal Cell Culture. 1973;IRL Press, Oxford.
19. Auffray C., Rougen F. Purification of mouse immunoglobulin heavy-chain messenger RNAs from total myeloma tumor RNA. Eur. J. Biochem. 107:1980;303-314.
20. Kruisbeek A.M. Current protocols in Immunology. 1992;Greene Publishing Associates.
21. Weissman A.M. Colligan J.E., Kruisbeek A.M., Marqulies D.H., Shevach E.M., Strober W. Current protocols in Immunology. 1992;Greene Publishing Associates.
22. Aguilar-Diosdado M., Parkinson D., Corbett J.A., Kwon G., Marshall C.A., Gingrich R.L., Santiago J.V., McDaniel M.L. Potential autoantigens in IDDM: Expression of carboxypeptidase-H and insulin but not glutamic acid decarboxylase on the β-cell surface. Diabetes. 43:1994;418-425.
23. Gelber C., Paborsky L., Singer S., McAteer D., Tisch, Jolicoeur C., Buelow R., McDevitt H., Fathman C.G. Isolation of nonobese diabetic mouse T-cells that recognize novel autoantigens involved in the early events of diabetes. Diabetes. 43:1994;33-39.
24. Sadelain M.W.J., Qin H.Y., Lauzon J., Singh B. Prevention of Type 1 diabetes in NOD mice by adjuvant immunotherapy. Diabetes. 39:1990;583-589.
25. Qin H.Y., Sadelain M.J.W., Hitchon C., Lauzon J., Singh B. Complete Freunds adjuvant-induced T cells prevent the development and adoptive transfer of diabetes in nonobese diabetic mice. J. Immunol. 150:1993;2072-2080.
26. +. Immunol. Today. 16:1995;35-38.
27. Howell S.L. The mechanism of insulin secretion. Diabetologia. 27:1984;319-327.
28. Schwartz R.H. Models of T cell anergy: Is there a common molecular mechanism? J. Exp. Med. 184:1996;1-8.
29. Weiner H.L., Friedman A., Miller A., Khoury S.J., Al-Sabbagh A., Santos L., Sayegh M., Nussenblatt R.B., Trenghanm D.E., Hafler D.A. Oral tolerance: immunologic mechanisms and treatment of animal and human organ-specific autoimmune diseases by oral administration of autoantigens. Annu. Rev. Immunol. 12:1994;809-837.
30. Atkinson M.A., Maclaran N.K., Luchetta R. Insulitis and diabetes in NOD mice reduced by prophylactic insulin therapy. Diabetes. 39:1990;933-937.